Nasdaq Stockholm

Meds apotek AB

ISIN SE0018014110Filings at the FI

At a glance

Most recent filing on August 20, 2026 — an open-market purchase by Björn Thorngren on Aug 20, 2026.

We hold 25 visible filings, going back to September 22, 2025.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 25 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 25. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Björn Thorngren Chief executive officer
50,800 SEKOpen-market buy
TradedAug 20, 2026FiledAug 20, 2026
Björn Thorngren Chief executive officer
53,500 SEKOpen-market buy
TradedJun 4, 2026FiledJun 4, 2026
Björn Thorngren Chief executive officer
3,195 SEKOpen-market buy
TradedJun 4, 2026FiledJun 4, 2026
Christian Jansson Chair of the board
99,000 SEKOpen-market buy
TradedMay 8, 2026FiledMay 8, 2026
Björn Thorngren Chief executive officer
31,704 SEKOpen-market buy
TradedMay 5, 2026FiledMay 6, 2026